Use-results survey for Bilanoa 20 mg tablet

Trial Profile

Use-results survey for Bilanoa 20 mg tablet

Phase of Trial: Phase IV

Latest Information Update: 25 Jul 2017

At a glance

  • Drugs Bilastine (Primary)
  • Indications Allergic rhinitis; Dermatitis; Eczema; Pruritus; Urticaria
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Taiho Pharmaceutical
  • Most Recent Events

    • 25 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top